help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dombrowski, F.
Right arrow Articles by Pfeifer, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dombrowski, F.
Right arrow Articles by Pfeifer, U.

American Journal of Pathology, Vol 152, 1025-1038, Copyright © 1998 by American Society for Investigative Pathology


REGULAR ARTICLES

Insulinomas derived from hyperplastic intra-hepatic islet transplants

F Dombrowski, D Klingmuller and U Pfeifer
Department of Pathology, University of Bonn, Germany. dombi@mailer.meb.uni-bonn.de

Insulinomas were induced in a new animal model by transplanting a low number of isologous pancreatic islets via the portal vein into the livers of 66 streptozotocin-induced diabetic rats. In contrast to high- number islet transplantation, which restored normoglycemia in 25 control animals, the low-number islet transplantation was followed by persisting hyperglycemia for at least 13 months. Hyperplasia of islet cells developed in the transplanted islets as a consequence of hyperglycemia, which for the beta cells is not only a secretory but also a proliferative stimulus. Six of thirty-three animals between the 18th and the 24th month after islet transplantation changed from hyperglycemia to severe hypoglycemia, due to insulinomas that had developed in the liver from the transplanted islets. In contrast to other animal models, insulinoma development in this new model does not result from DNA damage by chemicals or radiation or from the expression of transgenes, but starts from apparently normal islets prepared from untreated isologous donors, which are exposed to an imbalance in glucose metabolism. The persistent proliferative stimulus and the metabolic alterations caused by the longstanding hyperglycemia seem to be the most relevant oncogenic factors in this model.


This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Dombrowski, C. Mathieu, and M. Evert
Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats
Cancer Res., February 1, 2006; 66(3): 1833 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Dombrowski, C. M. Jost, S. Manekeller, and M. Evert
Cocarcinogenic Effects of Islet Hormones and N-Nitrosomorpholine in Hepatocarcinogenesis after Intrahepatic Transplantation of Pancreatic Islets in Streptozotocin-Diabetic Rats
Cancer Res., August 1, 2005; 65(15): 7013 - 7022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Dombrowski, L. Klotz, H. J. Hacker, Y. Li, D. Klingmuller, K. Brix, V. Herzog, and P. Bannasch
Hyperproliferative Hepatocellular Alterations after Intraportal Transplantation of Thyroid Follicles
Am. J. Pathol., January 1, 2000; 156(1): 99 - 113.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.